Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis
2007
Tumour-cell invasion and migration: diversity and escape mechanisms
2003 Standout
Untangling the ErbB signalling network
2001 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
ErbB-targeted therapeutic approaches in human cancer
2003
Poor outcome in patients with advanced stage neuroblastoma and coincident opsomyoclonus syndrome
1994
Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas
1992
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo
1995 Standout
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
1991
Rationale, Design, and Methods for Glycemic Control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
2006
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Pancreatic cancer
2020 Standout
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice
2000
Cachectin/tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor.
1989 StandoutNobel
TGFβ signalling in context
2012 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma
1990
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
1996 Standout
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Ligand Activation of Overexpressed Epidermal Growth Factor Receptor Results in Loss of Epithelial Phenotype and Impaired RGD-Sensitive Integrin Function in HSC-1 Cells
1996
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Length of Telomeric Repeats in Neuroblastoma: Correlation with Prognosis and Other Biological Characteristics
1992
Signals controlling the expression of PDGF
1996
Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma
1993
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Prognostic factors in Neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis
1988
Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells☆☆☆
1998
Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas
1995 Standout
Adenoviral Gene Transfer of β3 Integrin Subunit Induces Conversion from Radial to Vertical Growth Phase in Primary Human Melanoma
1998
AUTOCRINE AND PARACRINE REGULATION BY CYTOKINES AND GROWTH FACTORS IN MELANOMA
2000
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 Standout
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
1994 StandoutNature
Expression of TGF‐α/EGF and TGF‐p receptors in human colon carcinoma cell lines
1989
Molecular biology and genetics of human neuroblastoma
1989
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
TGFβ in Cancer
2008 Standout
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix
1989
Expression of platelet-derived growth factor (PDGF)-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo
1996
Neuroblastoma
2007 Standout
Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo.
1997
Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma
1988
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Prognostic significance of DNA di-tetraploidy in neuroblastoma
2001
Cancer and the chemokine network
2004 Standout
Genetic parameters of neuroblastomas
2002
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Selection of Maternal Human Immunodeficiency Virus Type 1 Variants in Human Placenta
1999 StandoutNobel
INTERFERON-β FROM MELANOMA CELLS SUPPRESSES THE PROLIFERATIONS OF MELANOMA CELLS IN AN AUTOCRINE MANNER
2002
Antisense targeting of basic fibroblast growth factor and dibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth
1997
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases
1991
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.
1999
Role of CXCL1 in tumorigenesis of melanoma
2002
Role of Growth Factors and Their Receptors in the Development and Progression of Melanoma
1993
A Class I Antigen, HLA-G, Expressed in Human Trophoblasts
1990 StandoutScience
A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
1994 Science
Hyperdiploidy Plus Nonamplified MYCN Confers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study
2005
Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
1994
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
2013 Standout
Contact with Thymic Epithelial Cells as a Prerequisite for Cytokine-Enhanced Human Immunodeficiency Virus Type 1 Replication in Thymocytes
1998 StandoutNobel
Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
1994
Tumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells.
1993
TGF-β-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
2010
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
1997 StandoutNobel
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
1994 StandoutScience
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
1999 Standout
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Dependence of a human squamous carcinoma and associated paraneoplastic syndromes on the epidermal growth factor receptor pathway in nude mice.
1991
Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas.
1994
Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia
2002
Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer
2003
Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
1997 Standout
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
1991
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Purification, Characterization, andin vitroDifferentiation of Cytotrophoblasts from Human Term Placentae*
1986 Standout
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
1990
Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin
2000
Works of Michael Varello being referenced
Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects.
1987
Pathophysiology of Tumor Progression in Human Gallbladder: Flow Cytometry, CEA, and CA 19-9 Levels in Bile and Serum in Different Stages of Gallbladder Disease
1989
Constitutive Expression of Multiple Growth Factor Genes by Melanoma Cells but Not Normal Melanocytes
1991
Platelet collagen receptor glycoprotein VI as a novel risk factor for myocardial infarction
2003
Flow cytometric DNA analysis of neuroblastoma. Correlation with histology and clinical outcome
1986
Flow cytometric DNA analysis as a diagnostic aid for cervical condyloma and cancer
1984